Biomark Capital Management Co. LLC current holdings: USA Other Stocks
Biomark Capital Management Co. LLC reported $0.07 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 2 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are JUNO THERAPEUTICS, INC., MABVAX THERAPEUTICS HOLDINGS, INC..
- JUNO THERAPEUTICS, INC.: Country of operation —; Class COM; Shares 2,168,601; Value $65,080,000.
- MABVAX THERAPEUTICS HOLDINGS, INC.: Country of operation —; Class COM NEW; Shares 26,708; Value $113,000.
Form 13F-HR as filed (SEC CIK 1667082): quarter ended 2016-09-30, filed 2016-11-09. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||